NDC 55150-119
Piperacillin and Tazobactam 2 g / 0.25 g injection, powder, lyophilized, for solution
On the label: AuroMedics Pharma LLC.
Where it's made
| Factory | Where | Role | Last FDA inspection |
|---|---|---|---|
| Aurobindo Pharma Limited | Medchal, India | Makes it and tests it | Serious problems, FDA actionSep 5, 2025 · 8 inspections, 1 with FDA action |
| Eugia Sez Private Limited | Mahabubnagar, India | Makes it, tests it and packages it | Problems found, fixed voluntarilyMar 1, 2019 · 2 inspections |
Recalls
- Jul 2, 2018 · Class I · AuroMedics Pharma LLC
Presence of Particulate Matter: identified as glass and silicone material
Lots: Lot: PP0317059-A; Exp February 2019: PP0317012-A, Exp: August 2019. - May 1, 2018 · Class I · AuroMedics Pharma LLC
Presence of Particulate Matter: confirmed customer report for presence of visible particulate matter, confirmed as glass
Lots: Lot #s: PP0317061-A, PP0317049-A; EXP August 2019
Class I recalls are the most serious; Class III the least. A recall covers specific lots, listed on each recall.
Product details
- Generic drug
- Piperacillin and Tazobactam: every company that makes it
- Form
- injection, powder, lyophilized, for solution, intravenous
- Strength
- 2 g / 0.25 g
- Approval
- ANDA ANDA065498
- On the market since
- Jan 23, 2012
- Package NDCs
55150-119-30- Official label
- DailyMed (National Library of Medicine), updated Aug 19, 2025
Got it by mail or from a pharmacy you don't know? Look the pharmacy up on Who Filled My Rx?